EPISODE · Jul 15, 2026 · 7 MIN
今天3分钟我们来聊聊单次输注2亿个干细胞，随访52周类风湿关节炎患者症状显著改善
from 源于细胞BioInsid的个人播客
类风湿关节炎是一种免疫系统攻击自身关节的慢性炎症疾病，目前治疗存在副作用和耐药性问题。一项研究显示，单次静脉输注自体脂肪来源间充质干细胞对难治性患者有显著效果，能维持52周症状改善，为患者带来新希望。 参考文献： Single intravenous infusion of autologous adipose-derived mesenchymal stem cells for active rheumatoid arthritis: a phase I/IIa open-label study. Stem Cell Research & Therapy, 2022. American College of Rheumatology. ACR66/68 response criteria for rheumatoid arthritis. 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊单次输注2亿个干细胞，随访52周类风湿关节炎患者症状显著改善
0:00
7:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 7 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on July 15, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!